Sharps Compliance Corp. (SMED) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sharps Compliance Corp. (SMED)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: JakeStraw	8/13/2014 7:47:16 AM
	of 9

Sharps Compliance Reports 46% Increase in Fiscal 2014 Fourth Quarter Customer Billings; 35% Increase in Revenue finance.yahoo.com 63% improvement in fourth quarter gross profit with 8% increase in SG&A demonstrates leverage on incremental sales growth Retail market billings increase 184% as compared to prior year fourth quarter Professional market billings increase 38% over prior year fourth quarter driven by solid traction from inside and online sales channel Pharmaceutical manufacturer market billings increase 91% over prior year fourth quarter and up 55% over comparative trailing twelve month period; Fourth quarter includes resupply orders for several existing patient support programs of the Company's pharmaceutical manufacturer customers Environmental market billings increase more than 200% as compared to fourth quarter of fiscal 2013 Balance sheet remains solid with a cash balance of $13.7 million and working capital of $17.9 million

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next